Sign in / Join Now
ETFs & Funds
IPO Preview: Revance Therapeutics $
Add a reply...
Latest StockTalks »
people get RVNC breaking news and analysis by email alert.
Get email alerts on RVNC »
Revance Therapeutics, Inc.
Get latest price
From other sites
Revance Provides Clinical Milestones And Financial Outlook For 2017
at TheStreet (Jan 5, 2017)
Revance Announces Positive 24-Week Duration Of Effect In Interim Results From Phase 2 Cervical Dystonia Trial
at TheStreet (Dec 12, 2016)
Revance To Participate In The 28th Annual Piper Jaffray Healthcare Conference
at TheStreet (Nov 17, 2016)
Revance To Participate In The Jefferies 2016 London Healthcare Conference
at TheStreet (Nov 7, 2016)
Revance Releases Third Quarter 2016 Results
at TheStreet (Nov 3, 2016)